Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| 1 |
Regeneron Pharmaceuticals
REGN
|
$884M |
| 2 |
JD.com
JD
|
$784M |
| 3 |
Dollar General
DG
|
$667M |
| 4 |
Monster Beverage
MNST
|
$324M |
| 5 |
Starbucks
SBUX
|
$249M |
Top Sells
| 1 |
Union Pacific
UNP
|
$611M |
| 2 |
Mondelez International
MDLZ
|
$554M |
| 3 |
Alibaba
BABA
|
$438M |
| 4 |
CELG
Celgene Corp
CELG
|
$408M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
$362M |
Sector Composition
| 1 | Healthcare | 21.02% |
| 2 | Consumer Discretionary | 16.05% |
| 3 | Technology | 13.06% |
| 4 | Communication Services | 12.46% |
| 5 | Financials | 9.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
PLCM
401
DELISTED
POLYCOM INC
PLCM
| $33.2M | 0.03% |
2,901,425
-1,007,986
| -26% | -$11.5M |
|
|
INN
402
Summit Hotel Properties
INN
$613M
| $32.9M | 0.03% |
2,532,266
+391,594
| +18% | +$5.09M |
|
|
ESRX
403
DELISTED
Express Scripts Holding Company
ESRX
| $32.2M | 0.03% |
+361,685
| New | +$32.2M |
|
404
Eagle Bancorp
EGBN
$596M
| $31.9M | 0.03% |
725,157
+290,101
| +67% | +$12.8M |
|
405
Atara Biotherapeutics
ATRA
$86.9M
| $31.6M | 0.03% |
23,979
+189
| +0.8% | +$249K |
|
406
CDW
CDW
$21.9B
| $31.6M | 0.03% |
922,594
+627,926
| +213% | +$21.5M |
|
407
BOK Financial
BOKF
$7.18B
| $31.2M | 0.03% |
448,567
+16,099
| +4% | +$1.12M |
|
|
UNVR
408
DELISTED
Univar Solutions Inc.
UNVR
| $31.1M | 0.03% |
+1,196,110
| New | +$31.1M |
|
409
Premier
PINC
$2.27B
| $30.8M | 0.03% |
800,513
-83,318
| -9% | -$3.2M |
|
410
Prosperity Bancshares
PB
$6.46B
| $30.3M | 0.03% |
524,746
-238,610
| -31% | -$13.8M |
|
|
PTLA
411
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $29.6M | 0.03% |
649,900
+6,543
| +1% | +$298K |
|
412
Wheaton Precious Metals
WPM
$48B
| $29.2M | 0.03% |
1,685,342
+7,412
| +0.4% | +$129K |
|
413
Benchmark Electronics
BHE
$1.44B
| $29.1M | 0.03% |
1,338,141
-25,109
| -2% | -$547K |
|
414
Insmed
INSM
$30.9B
| $28.6M | 0.03% |
1,171,996
+8,440
| +0.7% | +$206K |
|
415
Cogent Communications
CCOI
$1.8B
| $28.3M | 0.03% |
835,694
-186,475
| -18% | -$6.31M |
|
|
TAHO
416
DELISTED
Tahoe Resources Inc
TAHO
| $28.1M | 0.03% |
2,316,999
+826,489
| +55% | +$10M |
|
417
Caesarstone
CSTE
$48.7M
| $28M | 0.03% |
+408,813
| New | +$28M |
|
|
CMO
418
DELISTED
Capstead Mortgage Corp.
CMO
| $28M | 0.03% |
2,520,256
+208,411
| +9% | +$2.31M |
|
|
STKL
419
SunOpta
STKL
$753M
| $27.9M | 0.03% |
2,602,543
+1,253,084
| +93% | +$13.4M |
|
420
Core Laboratories
CLB
$592M
| $27.9M | 0.03% |
244,276
+241
| +0.1% | +$27.5K |
|
421
Heartland Express
HTLD
$666M
| $27.7M | 0.03% |
1,370,727
-895,745
| -40% | -$18.1M |
|
|
GWPH
422
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $27.5M | 0.03% |
223,805
-80,391
| -26% | -$9.88M |
|
|
PFPT
423
DELISTED
Proofpoint, Inc.
PFPT
| $27.4M | 0.03% |
430,078
-3,616
| -0.8% | -$230K |
|
424
DexCom
DXCM
$30.6B
| $27.3M | 0.03% |
1,364,212
+1,199,904
| +730% | +$24M |
|
|
GNMK
425
DELISTED
GenMark Diagnostics, Inc
GNMK
| $27.3M | 0.03% |
3,009,825
-669,492
| -18% | -$6.07M |
|